XML 20 R5.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
 [2]
Common Stock
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
 [2]
Accumulated Other Comprehensive Income (Loss), Net of Taxes
Balance (in shares) at Dec. 31, 2017 [1]     13,843,084      
Balance at Dec. 31, 2017 $ 297,025   $ 143,967 $ 155,544   $ (2,486)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 32,622     32,622    
Other comprehensive income (loss) $ (978)         (978)
Reclassification of stranded tax effects in AOCI       638   (638)
Stock options exercised (in shares) 157,192   111,714 [1]      
Stock options exercised, net of shares surrendered for cashless exercises and tax withholdings $ 538   $ 538      
Stock issued under employee stock purchase plan (in shares) [1]     1,036      
Stock issued under employee stock purchase plan 39   $ 39      
Stock issued under employee stock ownership plan (ESOP) (in shares) [1]     29,600      
Stock issued under employee stock ownership plan 1,173   $ 1,173      
Restricted stock granted (in shares) [1]     37,040      
Restricted stock granted $ 0          
Restricted stock surrendered for tax withholdings upon vesting (in shares) (46,794)   (1,316) [1]      
Restricted stock surrendered for tax withholdings upon vesting $ (45)   $ (45)      
Restricted stock forfeited/cancelled (in shares) [1]     (12,056)      
Restricted stock granted 0          
Stock-based compensation - stock options 651   $ 651      
Stock-based compensation - restricted stock 1,013   $ 1,013      
Cash dividends paid on common stock [1] (8,860)     (8,860)    
Stock purchased by directors under director stock plan (in shares) [1]     998      
Stock purchased by directors under director stock plan 37   $ 37      
Stock issued in payment of director fees (in shares) [1]     5,470      
Stock issued in payment of director fees $ 204   $ 204      
Stock repurchased, net of commissions (in shares) (171,217)   (171,217) [1]      
Stock repurchased, net of commissions $ (7,012)   $ (7,012)      
Balance (in shares) at Dec. 31, 2018 [1]     13,844,353      
Balance at Dec. 31, 2018 316,407   $ 140,565 179,944   (4,102)
Balance (in shares) at Dec. 31, 2017 [1]     13,843,084      
Balance at Dec. 31, 2017 $ 297,025   $ 143,967 155,544   (2,486)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock repurchased, net of commissions (in shares) (730,926)          
Balance (in shares) at Dec. 31, 2020 13,500,453   13,500,453 [1]      
Balance at Dec. 31, 2020 $ 358,253   $ 125,905 219,747   12,601
Balance (in shares) at Dec. 31, 2018 [1]     13,844,353      
Balance at Dec. 31, 2018 316,407   $ 140,565 179,944   (4,102)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 34,241     34,241    
Other comprehensive income (loss) $ 8,605         8,605
Stock options exercised (in shares) 48,108   45,553 [1]      
Stock options exercised, net of shares surrendered for cashless exercises and tax withholdings $ 669   $ 669      
Stock issued under employee stock purchase plan (in shares) [1]     1,355      
Stock issued under employee stock purchase plan 54   $ 54      
Stock issued under employee stock ownership plan (ESOP) (in shares) [1]     30,075      
Stock issued under employee stock ownership plan 1,245   $ 1,245      
Restricted stock granted (in shares) [1]     29,110      
Restricted stock granted $ 0          
Restricted stock surrendered for tax withholdings upon vesting (in shares) (7,795)   (5,240) [1]      
Restricted stock surrendered for tax withholdings upon vesting $ (220)   $ (220)      
Restricted stock forfeited/cancelled (in shares) [1]     (18,333)      
Restricted stock granted 0          
Stock-based compensation - stock options 495   $ 495      
Stock-based compensation - restricted stock 1,017   $ 1,017      
Cash dividends paid on common stock (10,958)     (10,958)    
Stock purchased by directors under director stock plan (in shares) [1]     591      
Stock purchased by directors under director stock plan 24   $ 24      
Stock issued in payment of director fees (in shares) [1]     5,544      
Stock issued in payment of director fees $ 231   $ 231      
Stock repurchased, net of commissions (in shares) (356,000)   (356,000) [1]      
Stock repurchased, net of commissions $ (15,022)   $ (15,022)      
Balance (in shares) at Dec. 31, 2019 13,577,008   13,577,008 [1]      
Balance at Dec. 31, 2019 $ 336,788 $ (1,216) $ 129,058 203,227 $ (1,216) 4,503
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 30,242     30,242    
Other comprehensive income (loss) $ 8,098         8,098
Stock options exercised (in shares) 73,208   65,407 [1]      
Stock options exercised, net of shares surrendered for cashless exercises and tax withholdings $ 1,304   $ 1,304      
Stock issued under employee stock purchase plan (in shares) [1]     2,392      
Stock issued under employee stock purchase plan 72   $ 72      
Stock issued under employee stock ownership plan (ESOP) (in shares) [1]     39,900      
Stock issued under employee stock ownership plan 1,289   $ 1,289      
Restricted stock granted (in shares) [1]     29,100      
Restricted stock granted $ 0          
Restricted stock surrendered for tax withholdings upon vesting (in shares) (10,001)   (2,200) [1]      
Restricted stock surrendered for tax withholdings upon vesting $ (73)   $ (73)      
Restricted stock forfeited/cancelled (in shares) [1]     (14,314)      
Restricted stock granted 0          
Stock-based compensation - stock options 319   $ 319      
Stock-based compensation - restricted stock 884   $ 884      
Cash dividends paid on common stock (12,506)     (12,506)    
Stock purchased by directors under director stock plan (in shares) [1]     1,146      
Stock purchased by directors under director stock plan 43   $ 43      
Stock issued in payment of director fees (in shares) [1]     5,723      
Stock issued in payment of director fees $ 217   $ 217      
Stock repurchased, net of commissions (in shares) (203,709)   (203,709) [1]      
Stock repurchased, net of commissions $ (7,208)   $ (7,208)      
Balance (in shares) at Dec. 31, 2020 13,500,453   13,500,453 [1]      
Balance at Dec. 31, 2020 $ 358,253   $ 125,905 $ 219,747   $ 12,601
[1] Share and per share data have been adjusted to reflect the two-for-one stock split effective November 27, 2018.
[2] Refer to Note 1, Summary of Accounting Policies, for information on the adoption of ASU 2016-13 in 2020.